Search

Financial results - CLINICAL ONCOLOGY RESEARCH SRL

0.00
Financial Summary - Clinical Oncology Research Srl
Unique identification code: 36829736
Registration number: J40/16288/2016
Nace: 7219
Sales - Ron
62.167
Net Profit - Ron
53.060
Employees
Open Account
Company Clinical Oncology Research Srl with Fiscal Code 36829736 recorded a turnover of 2024 of 62.167, with a net profit of 53.060 and having an average number of employees of - . The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Clinical Oncology Research Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 25.813 21.425 22.433 22.229 34.722 35.049 0 62.167
Total Income - EUR - - 25.813 21.425 22.457 22.229 34.722 35.049 0 62.167
Total Expenses - EUR - - 1.730 2.704 2.628 2.574 2.538 3.035 0 527
Gross Profit/Loss - EUR - - 24.082 18.722 19.829 19.655 32.184 32.015 0 61.639
Net Profit/Loss - EUR - - 23.308 18.079 19.156 19.018 31.143 30.984 0 53.060
Employees - - 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Clinical Oncology Research Srl

Rating financiar

Financial Rating -
CLINICAL ONCOLOGY RESEARCH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Clinical Oncology Research Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Clinical Oncology Research Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Clinical Oncology Research Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Clinical Oncology Research Srl - CUI 36829736

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 0 0 0 0 0 0 0 0
Current Assets - - 23.727 18.323 19.730 19.635 31.745 31.807 0 58.071
Inventories - - 0 0 0 0 0 0 0 0
Receivables - - 1.281 645 2.987 2.657 3.117 3.653 0 22.320
Cash - - 22.447 17.679 16.743 16.979 28.629 28.154 0 35.751
Shareholders Funds - - 23.352 18.122 19.198 19.059 31.183 31.025 0 53.101
Social Capital - - 44 43 42 41 40 41 0 40
Debts - - 376 201 532 576 562 782 0 4.971
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7219 - 7219"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 58.071 euro in 2024 which includes Inventories of 0 euro, Receivables of 22.320 euro and cash availability of 35.751 euro.
The company's Equity was valued at 53.101 euro, while total Liabilities amounted to 4.971 euro. Equity increased by 53.101 euro, from 0 euro in 2023, to 53.101 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Clinical Oncology Research Srl

Comments - Clinical Oncology Research Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.